Dashboard
Manage Tickers

HEPAHepion Pharmaceuticals, Inc.

Nasdaq hepionpharma.com


$ 0.75 $ 0.03 (3.53 %)    

Monday, 09-Sep-2024 15:55:19 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 0.75
$ 0.70
$ 0.71 x 100
$ 0.75 x 100
$ 0.70 - $ 0.75
$ 0.55 - $ 6.36
15,604
na
4.35M
$ 1.17
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-21-2024 03-31-2024 10-Q
3 04-16-2024 12-31-2023 10-K
4 11-20-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 04-10-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 04-08-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-16-2021 06-30-2021 10-Q
14 05-14-2021 03-31-2021 10-Q
15 03-31-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
17 08-12-2020 06-30-2020 10-Q
18 06-30-2020 03-31-2020 10-Q
19 05-14-2020 12-31-2019 10-K
20 11-14-2019 09-30-2019 10-Q
21 08-14-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-Q
23 03-14-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 11-14-2017 09-30-2017 10-Q
28 09-28-2017 06-30-2017 10-K
29 04-12-2017 03-31-2017 10-Q
30 02-14-2017 12-31-2016 10-Q
31 11-14-2016 09-30-2016 10-Q
32 09-28-2016 06-30-2016 10-K
33 05-13-2016 03-31-2016 10-Q
34 02-12-2016 12-31-2015 10-Q
35 11-12-2015 09-30-2015 10-Q
36 09-25-2015 06-30-2015 10-K
37 05-14-2015 03-31-2015 10-Q
38 02-12-2015 12-31-2014 10-Q
39 11-13-2014 09-30-2014 10-Q
40 09-29-2014 06-30-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

pharma-two-b-and-hepion-pharmaceuticals-files-registration-statement-on-form-f-4-related-to-proposed-merger-proposed-transaction-expected-to-close-in-q4
Pharma Two B and Hepion Pharmaceuticals Fi...
09/04/2024 13:28:54

The Registration Statement contains a proxy statement/prospectus in connection with the proposed merger transaction pursuant to...

hepion-pharmaceuticals-announces-interim-ceo-and-cfo-john-cavan-departs-executive-chairman-john-brancaccio-appointed-as-interim-ceo-and-cfo
Hepion Pharmaceuticals Announces Interim C...
08/07/2024 13:09:44

fatty-liver-focused-hepion-pharmaceuticals-agrees-to-merge-with-israel-based-parkinsons-disease-drug-developer
Fatty-Liver Focused Hepion Pharmaceuticals...
07/22/2024 13:19:44

Hepion Pharmaceuticals announces merger with Pharma Two B Ltd., creating a combined company focused on Parkinson's disease ...

hepion-pharmaceuticals-shares-are-trading-higher-after-the-company-announced-it-entered-into-a-definitive-merger-agreement-with-pharma-two-b-the-company-announced-a-29-million-private-placement-of-non-convertible-senior-notes-to-institutional-investors
Hepion Pharmaceuticals shares are trading ...
07/22/2024 12:22:12

Core News & Articles
Market-Moving News for July 22nd
07/22/2024 12:21:08

RR: 100% | Richtech Robotics Celebrates Completion of Installation of ADAM at Ghost Kitchens inside Dawsonville, GA Walmart MIR...

pharma-two-b-to-go-public-through-merger-with-hepion-pharmaceuticals-co-also-announces-29m-private-placement-of-non-convertible-senior-notes-to-institutional-investors
Pharma Two B To Go Public Through Merger W...
07/22/2024 12:06:06

sp-500-rises-over-1-zions-bancorp-shares-gain-after-q1-earnings
S&P 500 Rises Over 1%; Zions Bancorp Share...
04/22/2024 18:46:36

why-is-liver-disease-drug-developer-hepion-pharmaceuticals-stock-trading-lower-on-monday
Why Is Liver-Disease Drug Developer Hepion...
04/22/2024 18:14:15

Updates on Hepion Pharmaceuticals' ASCEND-NASH Trial, now in wind-down phase. Explore insights into Phase 2b study progress...

why-vaxxinity-shares-are-trading-lower-by-around-55-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Vaxxinity Shares Are Trading Lower By ...
04/22/2024 17:26:48

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
04/22/2024 16:31:48

gold-falls-sharply-matterport-shares-spike-higher
Gold Falls Sharply; Matterport Shares Spik...
04/22/2024 16:07:37

dow-jumps-over-100-points-chicago-fed-national-activity-rises-in-march
Dow Jumps Over 100 Points; Chicago Fed Nat...
04/22/2024 13:41:41

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
04/22/2024 12:07:03

hepion-pharmaceuticals-says-given-the-number-of-enrolled-nash-patients-to-date-and-the-low-probability-of-generating-relevant-efficacy-data-to-support-a-registrational-trial-with-our-current-cash-resources-we-have-opted-to-wind-down-the-program-and-assure-that-patients-are-transitioned-out-of-the-trial-in-a-safe-and-compliant-manner
Hepion Pharmaceuticals Says Given The Numb...
04/19/2024 21:06:26

"We are disappointed to announce the wind-down of our Phase 2 NASH trial, which we attribute entirely to resource constrain...

hepion-pharmaceuticals-shares-resumed-trading
Hepion Pharmaceuticals Shares Resumed Trading
04/19/2024 21:05:32

trading-halt-halt-status-updated-at-45500-pm-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 4:55:...
04/19/2024 20:55:05

hepion-pharmaceuticals-initiates-wind-down-activities-in-phase-2b-ascend-nash-trial
Hepion Pharmaceuticals Initiates Wind-Down...
04/19/2024 20:33:05

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for...

trading-halt-halted-at-42520-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 4:25:20 p.m. ET - ...
04/19/2024 20:25:24

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
02/19/2024 13:05:48

hepion-pharmaceuticals-announces-immediate-exercise-of-series-b-common-stock-purchase-warrant-of-980393-shares-for-gross-proceeds-of-approximately-2m
Hepion Pharmaceuticals Announces Immediate...
02/16/2024 13:10:13

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION